Table 5.
The change of concentrations of Bone metabolic markers in serum
Group | Ca (mmol/L) | P (mmol/L) | ALP (IU/L) | |
---|---|---|---|---|
Group I (n = 37) | Before taking isoflavone | 2.33 ± 0.10 | 0.95 ± 0.14 | 59.37 ± 18.66 |
After taking isoflavone | 2.53 ± 0.16* | 0.94 ± 0.14 | 53.9 ± 13.76* | |
Group II (n = 33) | Before taking isoflavone | 2.30 ± 0.09 | 0.97 ± 0.12 | 57.37 ± 18.18 |
After taking isoflavone | 2.39 ± 0.10* | 0.98 ± 0.11 | 56.53 ± 18.85 |
Concentrations of bone metabolic markers in serum of subjects in isoflavone group and placebo group after 6 months of treatment with soy isoflavone 90 mg/day. Experimental conditions and treatment procedures are given in Materials and Methods. Graph depicts (mean ± SD). Asterisk means significant against baseline before trial (*p<0.05), t test.